Management of iron overload in β-thalassemia patients:: Safety and efficacy of subcutaneous bolus injection of desferrioxamine and bloodletting

被引：0
|
作者：
Bradai, M. [1 ]
Lamraoui, F. [1 ]
Abad, M. T. [1 ]
机构：
[1] Inst Med, Blida, Algeria
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1147
引用
收藏
页码：422 / 422
页数：1
相关论文
共 50 条
  • [21] the Safety and Efficacy of Deferasirox for the Transplant Patients with Iron Overload
    Tachibana, Takayoshi
    Kanda, Junya
    Machida, Shinichiro
    Saitou, Takeshi
    Tanaka, Masatsugu
    Najima, Yuho
    Koyama, Satoshi
    Miyazaki, Takuya
    Yamamoto, Eri
    Takeuchi, Masahiro
    Morita, Satoshi
    Kanda, Yoshinobu
    Kanamori, Heiwa
    Okamoto, Shinichiro
    BLOOD, 2016, 128 (22)
  • [22] A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia
    Galanello, Renzo
    Kattamis, Antonis
    Piga, Antonio
    Fischer, Roland
    Leoni, Giovanbattista
    Ladis, Vassilios
    Voi, Vincenzo
    Lund, Ulrich
    Tricta, Fernando
    HAEMATOLOGICA, 2006, 91 (09) : 1241 - 1243
  • [23] EFFICACY AND SAFETY OF DEFERASIROX IN THE MANAGEMENT OF IRON OVERLOAD IN MYELOFIBROSIS ALSO IN PATIENTS TREATED WITH RUXOLITINIB
    Elli, E. M.
    Aroldi, A.
    Renso, R.
    Carrer, A.
    Gambacorti-Passerini, C.
    HAEMATOLOGICA, 2017, 102 : 98 - 99
  • [24] IMPROVEMENT IN IRON STATUS AND LIVER-FUNCTION IN PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD WITH LONG-TERM SUBCUTANEOUS DESFERRIOXAMINE
    HOFFBRAND, AV
    GORMAN, A
    LAULICHT, M
    GARIDI, M
    ECONOMIDOU, J
    GEORGIPOULOU, P
    HUSSAIN, MAM
    FLYNN, DM
    LANCET, 1979, 1 (8123): : 947 - 949
  • [25] IRON OVERLOAD, DESFERRIOXAMINE AND THE RISK OF INFECTION IN DIALYSIS PATIENTS
    BOELAERT, J
    ALUMINIUM AND IRON OVERLOAD IN HAEMODIALYSIS, 1989, : 62 - 66
  • [26] Continuous low-dose subcutaneous desferrioxamine (DFO) to prevent allergic manifestations in patients with iron overload
    Cianciulli, P
    Sorrentino, F
    Maffei, L
    Amadori, S
    ANNALS OF HEMATOLOGY, 1996, 73 (06) : 279 - 281
  • [27] PREVENTION OF HEART-DISEASE BY SUBCUTANEOUS DESFERRIOXAMINE IN PATIENTS WITH THALASSEMIA MAJOR
    RICHARDSON, ME
    MATTHEWS, RN
    ALISON, JF
    MENAHEM, S
    MITVALSKY, J
    BYRT, E
    HARPER, RW
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1993, 23 (06): : 656 - 661
  • [28] MANAGEMENT OF THALASSEMIA MAJOR - 15 YEARS EXPERIENCE WITH SUBCUTANEOUS DESFERRIOXAMINE AND HYPERTRANSFUSION THERAPY
    GIARDINA, PJ
    GRADY, RW
    EHLERS, KH
    NEW, MI
    HILGARTNER, MW
    CLINICAL RESEARCH, 1993, 41 (02): : A313 - A313
  • [29] EFFECTIVE IRON EXCRETION USING CONTINUOUS SUBCUTANEOUS DESFERRIOXAMINE INFUSIONS IN THALASSEMIA-MAJOR
    KONIG, R
    BECK, W
    JENTSCH, F
    SCHROTER, W
    TILLMANN, W
    MONATSSCHRIFT KINDERHEILKUNDE, 1982, 130 (08) : 685 - 685
  • [30] IRON STATE AND HEPATIC-DISEASE IN PATIENTS WITH THALASSEMIA MAJOR, TREATED WITH LONG-TERM SUBCUTANEOUS DESFERRIOXAMINE
    ALDOURI, MA
    WONKE, B
    HOFFBRAND, AV
    FLYNN, DM
    LAULICHT, M
    FENTON, LA
    SCHEUER, PJ
    KIBBLER, CC
    ALLWOOD, CA
    BROWN, D
    THOMAS, HC
    JOURNAL OF CLINICAL PATHOLOGY, 1987, 40 (11) : 1353 - 1359
12345